Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer

Urology

Volumn 64, Issue 1, 2004, Pages 74-78

  Ito, Masaaki ^b   Habuchi, Tomonori ^b   Watanabe, Jun ^b   Higashi, Shin ^b   Nishiyama, Hiroyuki ^b   Wang, Lizhong ^b   Tsuchiya, Norihiko ^b   Kamoto, Toshiyuki ^b   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CHI SQUARE TEST; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; EVALUATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS, ALKYLATING; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYCLIN D1; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOTHERAPY, ACTIVE; INCIDENCE; LIFE TABLES; MALE; MIDDLE AGED; MITOMYCIN; POLYMORPHISM, GENETIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENES; RISK; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 3042818713     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.03.001     Document Type: Article

References (28)

1. Foresman W.H., Messing E.M. Bladder cancer natural history, tumor markers, and early detection strategies. Semin Surg Oncol. 13:1997;299-306
2. Kinoshita H., Ogawa O., Yoshida O., et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst. 89:1997;724-730
3. Miyanaga N., Ohtani M., Akaza H., et al. Clinical statistical studies on bladder cancer in Japan. Nihon Rinsyo. 51:1993;823-829
4. Hudson M.A., Herr H.W. Carcinoma in situ of the bladder. J Urol. 153:1995;564-572. (review)
5. Markl I.D.C., Salem C.E., Jones P.A. Molecular biology of bladder cancer. Vogelzang J., Scardino R.T., Shipley W.U., et al. Comprehensive Textbook of Genitourinary Oncology. 2nd ed:1999;298-309 Lippincott, Williams & Wilkins, Philadelphia
6. Reznikoff C.A., Sarkar S., Julicher K.P., et al. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol. 5:2000;191-203
7. Lee C.C., Yamamoto S., Morimura K., et al. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer. 79:1997;780-789
8. Lee C.C., Yamamoto S., Wanibuchi H., et al. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes and cell proliferation. Cancer Res. 57:1997;4765-4776
9. Shin K.Y., Kong G., Kim W.S., et al. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br J Cancer. 75:1997;1788-1792
10. Suwa Y., Takano Y., Iki M., et al. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder. J Urol. 160:1998;897-900
11. Betticher D.C., Thatcher N., Altermatt H.J., et al. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 11:1995;1005-1011
12. Sawa H., Ohshima T.A., Ukita H., et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene. 16:1998;1701-1712
13. Wang L., Habuchi T., Takahashi T., et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis. 23:2002;257-264
14. Union Internationale Contré Cancer. UICC TNM Classification of Malignant Tumors. 5th ed:1997;Springer-Verlag, Berlin
15. The Japanese Urological Association and the Japanese Society of Pathology. General Rule for Clinical and Pathological Studies on Bladder Cancer. 2nd ed:1993;Kanahara-Shuppan, Tokyo
16. Mostofi FK, Sobin LH, and Torloni H: Histological typing of urinary bladder tumors, in International Histological Classification of Tumors, No. 10. Geneva, World Health Organization, 1973, pp 15-34
17. Catherine A.R., Somdatta S., Knut P.J., et al. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol. 5:2000;191-203
18. Hosokawa Y., Gadd M., Smith A.P., et al. Cyclin D1 (PRAD1) alternative transcript b full-length cDNA cloning and expression in breast cancers. Cancer Lett. 113:1997;123-130
19. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degraded proteins the PEST hypothesis. Science. 234:1986;364-368
20. Waf1-CIp1 during treatment of superficial bladder cancer. J Urol. 162:1999;225-230
21. Wagner U., Suess K., Luginbuhl T., et al. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer. J Pathol. 188:1999;44-50
22. Waf1-Cip1 and cyclin D1 expression in the progression of superficial bladder cancer. Urol Res. 28:2000;285-292
23. Kong S., Amos C.I., Luthra R., et al. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 60:2000;249-252
24. Dhar K.K., Branigan K., Howells R.E., et al. Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. Int J Gynecol Cancer. 9:1999;342-347
25. Matthias C., Branigan K., Jahnke V., et al. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 4:1998;2411-2418
26. Matthias C., Jahnke V., Jones P.W., et al. Cyclin D1, glutathione S-transferase and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers Prev. 8:1999;815-823
27. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677
28. Hunter T., Pines J. Cyclins and cancer II cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582